Form 4 for TNYA Tenaya Therapeutics, Inc.

Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-17 · accession 0000919574-22-006902 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2022-11-25	2022-11-17	TNYA	Casdin Capital, LLC	Dir	P - Purchase	$2.60	+2.49M	6.08M	+69%	+$6.48M
DI	2022-11-25	2022-11-17	TNYA	Casdin Capital, LLC	Dir	P - Purchase	$2.60	+1.35M	1.35M	New	+$3.52M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-11-17	P	A	2,492,042	$2.60	6,078,860	I See footnote	—	—	(F1) The securities are owned directly by clients of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such clients and (ii) Eli Casdin, the managing member of Casdin Capital.
2	Derivative	Warrant	2022-11-17	P	A	1,354,111	$2.60	1,354,111	I See footnote	$0.00 · 2022-11-17 to —	1,354,111 Common Stock	(F1) The securities are owned directly by clients of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such clients and (ii) Eli Casdin, the managing member of Casdin Capital. (F2) Each Warrant will be exercisable on or after the date of issuance until the date the Warrant is exercised in full. Each Warrant will be exercisable, in the holder's discretion, by (i) payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise or (ii) a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined according to a pre-set formula.